Bank Julius Baer & Co. Ltd Zurich Cuts Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Bank Julius Baer & Co. Ltd Zurich decreased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 29.8% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 585,335 shares of the medical equipment provider's stock after selling 248,271 shares during the quarter. Intuitive Surgical comprises about 1.0% of Bank Julius Baer & Co. Ltd Zurich's investment portfolio, making the stock its 21st largest holding. Bank Julius Baer & Co. Ltd Zurich owned about 0.16% of Intuitive Surgical worth $314,216,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in the business. Brighton Jones LLC boosted its holdings in Intuitive Surgical by 24.9% in the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock worth $1,916,000 after acquiring an additional 731 shares in the last quarter. Bank Pictet & Cie Europe AG raised its stake in Intuitive Surgical by 0.5% in the 4th quarter. Bank Pictet & Cie Europe AG now owns 190,969 shares of the medical equipment provider's stock worth $99,678,000 after acquiring an additional 883 shares during the last quarter. Hillsdale Investment Management Inc. grew its position in shares of Intuitive Surgical by 40.1% in the fourth quarter. Hillsdale Investment Management Inc. now owns 699 shares of the medical equipment provider's stock valued at $365,000 after purchasing an additional 200 shares in the last quarter. LPL Financial LLC increased its position in shares of Intuitive Surgical by 10.5% during the fourth quarter. LPL Financial LLC now owns 364,191 shares of the medical equipment provider's stock worth $190,883,000 after acquiring an additional 34,487 shares during the period. Finally, Crowley Wealth Management Inc. acquired a new stake in shares of Intuitive Surgical during the fourth quarter worth about $86,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Intuitive Surgical Stock Down 0.1%

Shares of ISRG stock traded down $0.42 during mid-day trading on Tuesday, reaching $515.70. The company's stock had a trading volume of 369,485 shares, compared to its average volume of 1,662,019. The company's 50 day simple moving average is $535.90 and its 200-day simple moving average is $536.29. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00. The firm has a market capitalization of $184.84 billion, a PE ratio of 75.62, a price-to-earnings-growth ratio of 5.50 and a beta of 1.64.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.10. The business had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. During the same period in the prior year, the firm earned $1.50 earnings per share. As a group, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the stock. Barclays dropped their price target on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a research note on Thursday, April 24th. Erste Group Bank upgraded Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Thursday, June 5th. Royal Bank Of Canada dropped their price target on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Citigroup reaffirmed a "buy" rating and issued a $650.00 price target (up previously from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. Finally, Deutsche Bank Aktiengesellschaft cut shares of Intuitive Surgical from a "hold" rating to a "sell" rating and reduced their price objective for the company from $515.00 to $440.00 in a research note on Monday, June 9th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat, Intuitive Surgical has a consensus rating of "Moderate Buy" and a consensus price target of $592.86.

Insiders Place Their Bets

In other news, EVP Gary Loeb sold 1,700 shares of the company's stock in a transaction dated Friday, April 25th. The stock was sold at an average price of $513.18, for a total value of $872,406.00. Following the completion of the sale, the executive vice president owned 2,245 shares of the company's stock, valued at $1,152,089.10. This represents a 43.09% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Jami K. Nachtsheim sold 2,400 shares of Intuitive Surgical stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total value of $1,248,000.00. Following the completion of the transaction, the director owned 6,371 shares in the company, valued at $3,312,920. The trade was a 27.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 4,998 shares of company stock valued at $2,611,577. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.